Executive Insights

We spoke to Enovis CEO Matt Trerotola about foundational implant technologies, ASC penetration, tech adoption and successful M&A deals....

Ortho execs on enabling technology’s important role in implant sales, recent M&A deals that worked and improving surgical procedure volumes....

Nanochon is targeting a $2 billion market in the U.S. with its Chondrograft implant for cartilage repair and replacement....

We round up third-quarter commentary from orthopedic executives as they focus on market expansion, technology, ASCs and staffing....

Stéphane Lavallée wants to increase access to robotic-assisted surgery for every company and across procedures with an open robotic system....

We spoke to the company about its progress in untangling itself from Zimmer Biomet, OUS markets and ZimVie’s medium-term priorities....

Randy Roof, Founder and CEO of Cutting Edge Spine, built his company believing he could do better for patients, surgeons...

We spoke to ZimVie CEO Vafa Jamali about the new opportunities and finding the right areas of the spine market...

What are the most significant opportunities and challenges for the orthopedic industry in 2022? Regulatory commentators weigh in....

The dust is starting to settle about what may be long-term in the orthopedic manufacturer-to-hospital supply chain and what may...